Evidence map›Paper›PMID 38251202›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Employing Piezoelectric Mg

Jiani Yang, Yaqian Du, Yuanfei Yao, Yuanyu Liao, Bojun Wang, Xuefan Yu, Kaikun Yuan, Yanqiao Zhang, Fei He, Piaoping Yang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Employing Piezoelectric MgAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jiani YangDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150001, P. R. China.
Yaqian DuKey Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin Engineering University, Harbin, 150001, P. R. China.
Yuanfei YaoDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150001, P. R. China.
Yuanyu LiaoDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150001, P. R. China.
Bojun WangDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150001, P. R. China.
Xuefan YuDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150001, P. R. China.
Kaikun YuanDepartment of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, 150001, P. R. China.
Yanqiao ZhangDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150001, P. R. China.
Fei HeKey Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin Engineering University, Harbin, 150001, P. R. China.
Piaoping YangKey Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin Engineering University, Harbin, 150001, P. R. China.ORCID 0000-0002-9555-1803
Harbin Medical University · CNHarbin Engineering University · CN

Funding

Haiyan Research Fund of Harbin Medical University Cancer Hospital JJMS2022-01Major Project of Heilongjiang Province Programs for Fundamental Research and Development 2022ZX06C01National Natural Science Foundation of China 51972076Natural Science Foundation of Heilongjiang Province LH2023H093Natural Science Foundation of Heilongjiang Province ZD2019E004Natural Science Foundation of Shandong Province ZR2019ZD29
6 · The paper itself

Abstract

Although immunogenic cell death (ICD) inducers evidently enhance the effectiveness of immunotherapy, their potential is increasingly restricted by the development of apoptosis resistance in tumor cells, poor immunogenicity, and low T-cell immune responsiveness. In this study, for the first time, piezoelectrically catalyzed Mg

Indexed as

Antineoplastic AgentsDurapatiteApoptosisCell Line, TumorNecroptosisReceptors, Death DomainAntineoplastic AgentsDurapatiteReceptors, Death DomainDR5hydroxyapatiteimmunotherapynecroptosispiezoelectric catalysis

Identifiers

PMID38251202
PMCPMC10987113
OpenAlexW4391090265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.